Article
LncRNA FTX promotes colorectal cancer radioresistance through disturbing redox balance and inhibiting ferroptosis via miR-625-5p/SCL7A11 axis
25 Apr 2025
Abstract excerpt
BACKGROUND Radiotherapy is widely employed in colorectal cancer (CRC) treatment, but the occurrence of radioresistance severely limits the clinical benefit to patients and significantly contributes to treatment failure and recurrent metastasis. AIM To explore the role and underlying mechanism of the lncRNA FTX in radiotherapy resistance in CRC. METHODS LncRNA FTX expression in colorectal parent cells (HT29 and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
